Delivery Order SPE2DB22D2006-SPE2DB25FW4CK
- Not listed
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,437.40 by the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, non-set-aside contract calls for the delivery of XELJANZ XR 11 mg tablets in quantities of 30 units. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,776.31 by the Defense Logistics Agency for XELJANZ XR 11 MG tablets (30-count units) under a firm fixed-price contract type. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary distribution...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 3, 2025, for XELJANZ XR 11 mg tablets in 30-count units, with a ceiling value of $10,286.16. This firm fixed price, non-set-aside contract is scheduled for completion by September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for XELJANZ XR 11 mg tablets in 30-count unit doses, valued at $18,565.52 under a firm fixed price contract type. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $17,873.07 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 8, 2025, for XELJANZ XR 11 mg tablets (30-count packages). The award, which carries an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 4, 2025, for Xeljanz 5 mg tablets (60-count units) under a firm fixed price contract with a ceiling value of $19,446.19. This is a non-set-aside competitive award funded by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of September 5, 2025. The place of performance is located in Conshohocken, Pennsylvania, where the vendor maintains its...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of XELJANZ XR 11 MG tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a ceiling value of approximately $55.1K and an ultimate completion date of September 5, 2025. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $64,243.98 to supply XELJANZ XR 11 mg tablets in 30-count units. This non-competitive delivery order, issued on August 13, 2025, represents a firm fixed-price transaction with an ultimate completion date of August 14, 2025. The place of performance is listed as the company's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET UU 30S. The delivery order has a ceiling value of $140,949.11 and a completion date of August 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $8,141.67, represents a non-competitive set-aside procurement and is scheduled for ultimate completion by August 1, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4CKDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $69,353.78 on September 9, 2025, for the supply of XELJANZ XR 11 mg tablets (30-count units) by the Defense Logistics Agency. This non-set-aside, competitively awarded contract carries a firm fixed price structure and is scheduled for completion by September 10, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This delivery order supports the Defense Health Agency and broader military healthcare operations by providing pharmaceutical commodities through the DLA Medical Supply Chain. AmerisourceBergen's substantial IDC vehicle enables the company to deliver a comprehensive range of pharmaceutical products and medical supplies globally, including specialty medications, brand-name and generic drugs, and vaccines. The award demonstrates the contractor's established capability to fulfill federal procurement requirements for critical medical products in support of military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $69.4k | 9/9/25 |